Covid19 Clinical Trial
Official title:
Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance
Detection of the incidence and types of arrhythmia and conduction block in COVID - 19 patients Detection and description of CMR patterns of myocardial injury in COVID-19 patients with arrhythmias.
COVID-19 has been declared a global pandemic by the World Health Organization and is
responsible for hundreds of thousands of deaths worldwide.
Early reports from China suggested an overall cardiac arrhythmia incidence of 17% in patients
hospitalized for COVID-19. A higher arrhythmia rate (44%) was observed in patients with
COVID-19 admitted to the intensive care unit (ICU). However, details of the type and burden
of arrhythmias in this population have not been elucidated.
Myocardial injury is common in patients with COVID-19, accounting for 7%-23% of reported
cases in Wuhan, China. Among COVID-related myocardial injury, etiologies vary and can include
myocarditis, myocardial infarction, sepsis-related myocardial injury, and/or stress induced
cardiomyopathy. Myocardial injury is associated with high risk of developing all types of
arrhythmia including atrial fibrillation, supraventricular tachycardia, ventricular
tachycardia, ventricular fibrillation, and variable degrees of heart block. Sudden cardiac
death was also reported.
The pathophysiology of COVID-19-related myocarditis is a combination of direct viral injury
and cardiac damage due to the host's immune response. Although the pathophysiology of
arrhythmias is still speculative, clinicians should provide prompt monitoring and treatment.
The long term impact of COVID-19 myocarditis remains unknown
Meanwhile, cardiac magnetic resonance (CMR) imaging is an integral test in the diagnosis of
myocardial injury. It can safely be used as a first-line diagnostic tool in the workup of
myocardial injury associated with COVID-19.
Investigators believe that proper diagnosis and management of COVID 19 related arrhythmias
and their etiology can lead to both in-hospital and long term reduction of morbidity and
mortality of this dangerous presentation of the disease.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
| Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
| Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
| Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
| Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
| Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
| Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
| Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
| Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
| Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
| Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
| Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
| Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
| Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
| Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |